Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines.
THOUSAND OAKS, Calif., Jan. 6, 2026 /PRNewswire/ -- Amgen (AMGN) today announced its acquisition of Dark Blue Therapeutics Ltd., a privately held biotechnology company based in the United Kingdom ...
Amgen has agreed to acquire UK-based biotech Dark Blue Therapeutics for up to $840m, making it the first pharma takeover of 2026. Through this transaction, Amgen will gain access to Dark Blue’s ...
Amgen recently announced that David M. Reese, M.D., its long-serving executive vice president and Chief Technology Officer, ...
Barchart on MSN
What to expect from Amgen's next quarterly earnings report
With a market cap of $191.8 billion, Amgen Inc. (AMGN) is a global biotechnology company that discovers, develops, ...
Amgen Inc. (NASDAQ:AMGN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. Amgen Inc. (NASDAQ:AMGN) has outperformed the broader market this year, supported by strong financial ...
Biotech giant Amgen on April 22 announced the retirement of David Reese, executive vice president and chief technology officer, who has been with the Thousand Oaks-based company for 21 years. Reese, ...
Boehringer Ingelheim and Amgen have both canned early-stage immunology candidates after the prospects showed little clinical promise. Germany drugmaker Boehringer has halted development of the oral ...
Amgen doubles down in New Albany: expansion plus solar, CO2 refrigeration and EV chargers as it chases carbon neutrality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results